NTST vs TECH · P/E 163, rev $162.8M vs P/E 65, rev $1.22B
Netstreit Corp (NTST) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Netstreit Corp (NTST) is a reit - retail company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NTST revenue for 2024-12-31 was $162.8M. Net income was -$12.0M. Revenue was up 23.4% from 2023-12-31 to 2024-12-31. NTST currently screens at market cap $1.91B and trailing P/E 162.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NTST currently screens at market cap $1.91B and trailing P/E 162.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NTST and TECH stock pages for the full models.
Not investment advice.